Verona Pharma (NASDAQ:VRNA)'s stock has reached an unprecedented peak, setting an all-time high at $56.49. This milestone underscores a remarkable period of growth for the $4.49 billion ...
Operator Good day, ladies and gentlemen, and welcome to Northrop Grumman's fourth quarter 2024 conference call. Today's call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback